Roquette showcases drug delivery solutions at CPHI China
Analysis based on 8 articles · First reported Jun 10, 2026 · Last updated Jun 10, 2026
This event is positive for Roquette Frères as it highlights its commitment to innovation and market expansion in the pharmaceutical sector. The showcase of advanced drug delivery solutions and excipients could lead to increased partnerships and market share for Roquette Frères, particularly in China and the MSCI Asia Pacific Index region.
Roquette Frères, a global leader in plant-based ingredients and pharmaceutical excipients, is showcasing its comprehensive portfolio of innovative drug delivery solutions at CPHI & PMEC China 2026 in Shanghai. Under the theme 'One Roquette Frères for Innovations,' the company's Health & Pharma Solutions Business Unit will highlight its scientific expertise and technical capabilities to help pharmaceutical companies scale formulations. Angela Strzelecki, Senior Vice President of the Roquette Frères Group, emphasized Roquette Frères's integrated portfolio and commitment to being a trusted partner in China and the MSCI Asia Pacific Index region. Key products like PEARLITOL mannitol, manufactured in China, will be featured, along with other high-performance excipients, formulation technologies, biopharmaceutical solutions, and hard capsules.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard